Examples of using Reference veterinary in English and their translations into Romanian
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Melosus is a‘generic' which means that Melosus is similar to a‘reference veterinary medicine' already authorised in the EU(Metacam).
(a) there are changes in the active substance(s), therapeutic indications, strength, pharmaceutical form orroute of administration of the generic veterinary medicinal product compared to the reference veterinary medicinal product, or.
Recocam is a‘generic' medicine which means that Recocam is similar to a‘reference veterinary medicine' already authorised in the EU(Metacam).
Where it differs significantly in respect of those properties, the applicant shall submit additional information in order to prove the safety and/or efficacy of the various salts, esters orderivatives of the authorised active substance of the reference veterinary medicinal product.
Rheumocam is a‘generic',which means that Rheumocam is similar to a‘reference veterinary medicine' already authorised in the EU(Metacam).
(6)‘generic veterinary medicinal product' means a veterinary medicinal product which has the same qualitative and quantitative composition of active substances and the same pharmaceutical form asthe reference medicinal product, and with regard to which appropriate bioavailability studies have demonstrated a bioequivalence with the reference veterinary medicinal product;
(c) documentation referred to in Article 7(1)(b)is available for the reference veterinary medicinal products to the competent authority or to the Agency;
Where the reference veterinary medicinal product was not authorised in the Member State in which the application for the generic medicinal product is submitted, or the application is submitted in accordance with Article 38(3) where the reference medicinal product was authorised in a Member State, the applicant shall indicate in its application the Member State in which the reference veterinary medicinal product has been authorised.
(c) documentation referred to in Article 7(1)(b)is available for the reference veterinary medicinal product to the competent authority or to the Agency.
By way of derogation from Article 16(1)(b), an applicant for a marketing authorisation for a generic veterinary medicinal product shall not be required to provide the documentation on safety and efficacy if he demonstrates in the form of a letter of access that he is allowed to use the documentation on safety and efficacy referred to in Article 7(1)(b)which is available for the reference veterinary medicinal product.
This means that Meloxidolor is similar to a‘reference veterinary medicine' containing the same active substance, but it is also available at a higher strength.
Generic veterinary medicinal products shall not be placed on the market until the period of the protection of technical documentation for the reference veterinary medicinal product as set out in Articles 34 and 35 has elapsed.
In case of generic veterinary medicinal products, the parts of the summary of the product characteristics of the reference veterinary medicinal product that refer to indications or pharmaceutical forms which are protected by patent law in a Member State at the time of placing the generic veterinary medicinal product on the market may be omitted.
(b) the applicant can demonstrate that the application concerns a generic veterinary medicinal product of a veterinary medicinal product which has been authorised by a Member State orby the Commission, and the period of protection of the technical documentation in respect of that reference veterinary medicinal product laid down in Articles 34 and 35 has elapsed or is due to elapse in less than 2 years(‘reference veterinary medicinal product');
Studies have been carried out to prove that Melosus is‘bioequivalent' to the reference veterinary medicine which means that Melosus is equivalent to Metacam in the way it is absorbed and used by the body.
(b) the applicant can demonstrate that the veterinary medicinal product is a combination of reference veterinary medicinal products as referred to in Article 16(1)(b);
Studies have been carried out to prove that Acticam is‘bioequivalent' to the reference veterinary medicine: this means that Acticam is equivalent to Metacam 1.5 mg/ml suspension in the way it is absorbed and used by the body.
A competent authority or the Agency may require the applicant to provide safety data concerning the potential risks posed by the generic veterinary medicinal product to the environment in case the marketing authorisation for the reference veterinary medicinal product was granted before 20 July 2000 or in case the second phase environmental risk assessment was required for the reference veterinary medicinal product.
However, that requirement shall not apply to those parts of the summary of the product characteristics of the reference veterinary medicinal product that refer to indications or pharmaceutical forms which are still covered by patent law at the time when the generic veterinary medicinal product is authorised.
For the purpose of this Section, where the active substance consists of salts, esters, ethers, isomers and mixtures of isomers, complexes orderivatives differing from the active substance used in the reference veterinary medicinal product, it shall be considered to be the same active substance as that used in the reference veterinary medicinal product, unless it differs significantly in respect of properties with regard to safety or efficacy.
Try the reference of Veterinary Pharmaceuticals and Biologicals.
